Surprisingly, in pancreatic cancer, although ADAMTS1 levels were much lower in comparison to noncancerous pancreatic tissue, patients with lymph node metastasis or severe retroperitoneal invasion exhibited higher levels of ADAMTS1 expression and poorer recovery rates [82]. This evidence concerns the gene ADAMTS1 and familial pancreatic carcinoma.